Zepp Health Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Zepp Health wird ein Gewinn- und Umsatzwachstum von 111% bzw. 11.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 145% pro Jahr wachsen soll.

Wichtige Informationen

111.0%

Wachstumsrate der Gewinne

145.0%

EPS-Wachstumsrate

Electronic Gewinnwachstum	18.1%
Wachstumsrate der Einnahmen	11.8%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	27 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Aug 20

Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Aug 03

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Apr 17

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Dec 23

Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?

Feb 23

Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh

Jan 06

When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?

Dec 15

Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist

Oct 28

Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch

Oct 15

Zepp: A Solid International Diversification Play

Oct 03

Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?

Sep 13

Zepp Health: Taking Over The Smart Health Wearables Market

Jul 14

We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt

Jul 07

Gewinn- und Umsatzwachstumsprognosen

NYSE:ZEPP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	234	-4	5	N/A	1
12/31/2024	197	-34	-2	N/A	1
9/30/2024	209	-39	N/A	N/A	N/A
6/30/2024	237	-25	N/A	N/A	N/A
3/31/2024	296	-25	N/A	N/A	N/A
12/31/2023	352	-30	40	42	N/A
9/30/2023	406	-38	N/A	N/A	N/A
6/30/2023	492	-41	N/A	N/A	N/A
3/31/2023	587	-49	N/A	N/A	N/A
12/31/2022	601	-42	-116	-114	N/A
9/30/2022	665	-25	N/A	N/A	N/A
6/30/2022	766	-16	N/A	N/A	N/A
3/31/2022	924	14	N/A	N/A	N/A
12/31/2021	983	22	-45	-37	N/A
9/30/2021	1,017	34	N/A	N/A	N/A
6/30/2021	1,114	38	N/A	N/A	N/A
3/31/2021	991	26	N/A	N/A	N/A
12/31/2020	986	35	11	24	N/A
9/30/2020	968	47	N/A	N/A	N/A
6/30/2020	877	63	N/A	N/A	N/A
3/31/2020	861	73	N/A	N/A	N/A
12/31/2019	835	82	55	61	N/A
9/30/2019	689	67	N/A	N/A	N/A
6/30/2019	603	57	N/A	N/A	N/A
3/31/2019	575	58	N/A	N/A	N/A
12/31/2018	530	16	93	103	N/A
9/30/2018	462	4	N/A	N/A	N/A
6/30/2018	389	-10	N/A	N/A	N/A
3/31/2018	367	-22	N/A	N/A	N/A
12/31/2017	315	7	N/A	37	N/A
9/30/2017	287	8	N/A	44	N/A
12/31/2016	224	-2	N/A	2	N/A
12/31/2015	138	-9	N/A	-1	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: ZEPPDie Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: ZEPPDie Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ZEPP in 3 Jahren voraussichtlich hoch sein wird

Zepp Health Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2024

Consensus revenue estimates fall by 32%

Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2024

Price target increased by 30% to US$5.19

Consensus EPS estimates fall by 97%

Price target increased by 29% to US$3.99

Recent updates

Now 24% undervalued after recent price drop

Third quarter 2024 earnings released: US$0.82 loss per share (vs US$0.027 profit in 3Q 2023)

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2024

Zepp Health Corporation to Report Q3, 2024 Results on Nov 18, 2024

Zepp Health Regains Compliance with NYSE Minimum Price Continued Listing Criterion

Zepp Health Corporation Announces Board Changes

Zepp Health Corporation Announces Board Changes, Effective from September 1, 202

Consensus revenue estimates fall by 32%

Second quarter 2024 earnings released: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)

Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2024

New minor risk - Share price stability

Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Now 25% overvalued

Zepp Health Corporation to Report Q2, 2024 Results on Aug 21, 2024

Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Price target increased by 30% to US$5.19

Now 22% overvalued

Zepp Health Corporation Introduces Zepp OS 4

New major risk - Revenue and earnings growth

Zepp Health Corporation to Report Q1, 2024 Results on May 20, 2024

Zepp Health Announces US Launch Date for Amazfit Helio Ring

Full year 2023 earnings: EPS and revenues miss analyst expectations

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Consensus EPS estimates fall by 97%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Zepp Health Corporation to Report Q4, 2023 Results on Mar 18, 2024

Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

New minor risk - Share price stability

Price target increased by 29% to US$3.99

Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales

Third quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.28 loss in 3Q 2022)

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2023

Zepp Health Corporation to Report Q3, 2023 Results on Nov 20, 2023

Zepp Health Corporation Launches Amazfit Balance with AI-Empowered Features for the Ultimate in Balanced Living

Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2023

Second quarter 2023 earnings released: CN¥1.15 loss per share (vs CN¥1.74 loss in 2Q 2022)

Zepp Health Corporation to Report Q2, 2023 Results on Aug 21, 2023

Zepp Health Corporation Announces Amazfit Makes the New Amazfit Bip 5 Globally Available

Can Zepp Health Find Its Way Back Up?

Amazfit Launches New Amazfit Cheetah Series

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2023

First quarter 2023 earnings released: CN¥2.23 loss per share (vs CN¥1.42 loss in 1Q 2022)

Zepp Health Corporation to Report Q1, 2023 Results on May 23, 2023

Full year 2022 earnings released: CN¥4.68 loss per share (vs CN¥2.19 profit in FY 2021)

Third quarter 2022 earnings released: CN¥0.28 loss per share (vs CN¥0.78 profit in 3Q 2021)

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2022

Amazfit Launches Challenge on Adidas Apps Following Partnership Announcement

Price target decreased to US$2.75

Less than half of directors are independent

Zepp Health Corporation to Report Q3, 2022 Results on Nov 21, 2022

Amazfit Unveils Next-Level Sports and Lifestyle Experiences with the New Amazfit GTR 4 and GTS 4 Smartwatches

Second quarter 2022 earnings released: CN¥1.74 loss per share (vs CN¥1.47 profit in 2Q 2021)

Zepp Health Corporation Provides Earnings Guidance for the Third Quarter of 2022

Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M

Investor sentiment improved over the past week

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Zepp Health Corporation to Report Q2, 2022 Results on Aug 25, 2022

Amazfit Launches its Latest Firmware Update for OTS Rugged Outdoor GPS Smartwatch, the Amazfit T-Rex 2

Amazfit Unveils Newest Compact and Power-Packed Smartwatch, the Amazfit GTS 4 Mini

Amazfit Sends the Super-Tough T-Rex 2 Smartwatch on A Space Ride

Amazfit Introduces Best-Value Essential Smartwatch Additions, the Amazfit Bip 3 and Bip 3 Pro

Zepp Health Corporation, Annual General Meeting, Jul 05, 2022

Zepp: Speculative, But With Potentially Great Rewards

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022

Price target decreased to US$5.53

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022

Zepp Health Corporation to Report Q1, 2022 Results on May 24, 2022

Full year 2021 earnings released: EPS: CN¥2.19 (vs CN¥3.68 in FY 2020)